Home›Companies›Biotech & Pharma›VitriVax

VitriVax, Inc.

Updated Oct 29, 2026·Latest SEC filing Nov 17, 2025·Suggest an edit

About VitriVax

VitriVax is a private company based in Boulder, Colorado. It has reported $29,430,356 raised in one offering on Form D since November 2025. Its chief executive is Romulo Colindres.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 30, 2025Nov 17, 2025$29,430,356of $37.1M target83$354KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on VitriVax's Form D filed Nov 17, 2025.

GR
RL
Rene Lorenz
Director
LB
Louise Brady
Director
RC
Romulo Colindres
President/CEO and director

Sources

  1. SECVitriVax, Inc. filing history